Just a few months after the 2015 outbreak of Ebola was contained, another virus—called Zika—commanded the public stage. It took but 14 months after Zika’s first detection in Brazil for the virus to spread through Latin America and the Caribbean to Florida. So far, the threat has gone unchecked. And to be sure, after Zika, will come another global pathogenic threat—one, that public health experts worry, may do an even better job of outsmarting and overwhelming us. The question is whether technological advances can help us turn the odds. Can big data and genomic virus sequencing help us track emerging diseases, contain their spread and ultimately find antidotes for the next unknown pathology? Can it speed up the hunt for lifesaving vaccinations or drugs? The answers have an urgency like few others.
Follow along live here at 7:30 EST/4:30 PST on November 1st.
KEYWORDS: Health, Events, Conferences & Webinars, GSK, GlaxoSmithKline, public health, Zika, ebola, Fortune Brainstorm Health, Moncef Slaoui